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Abstract
Background: The use of complementary and alternative medicine (CAM) is on the increase globally with
a high prevalence in children and adults with chronic illnesses. Many studies have evaluated the
epidemiology of medicine use for children in developing countries but none has evaluated the use of CAM
for children with chronic illnesses. The aim of this study was therefore to determine the prevalence,
pattern of use, parental sources of information, perceived benefits, cost, and adverse effects of CAM in
children with epilepsy, sickle cell anaemia and asthma in Lagos, Nigeria.
Methods: Parents of children with epilepsy (122), asthma (78) or sickle cell anaemia (118) who presented
consecutively to the paediatric neurology, respiratory and haematology clinics of the Lagos State
University Teaching Hospital (LASUTH), Ikeja were interviewed with a structured open- and close-ended
questionnaire. The information obtained comprised the demography of both the patients and their
parents; past and present treatments received by the patients; the type of CAM, if any, used by the patients;
and the sources, cost, benefits and adverse effects of the CAM used.
Results: A total of 303 CAMs were used by the patients, either alone or in combination witother CAM.
CAM was reportedly used by 99 (31%) patients (epilepsy -38%, sickle cell anaemia – 36% and asthma –
25%). The majority (84%) of these patients were currently using CAM. The use of CAM was stopped six
months prior to the study by 16 patients (16%). Biological products were the most frequently used CAMs
(58%), followed by alternative medical systems (27%) and mind-body interventions (14%). Relations,
friends and neighbours had a marked influence on 76% of the parents who used CAM for their children.
Eighty-five (86%) parents were willing to discuss the use of CAM with their doctors but were not asked.
CAM use was associated with adverse reactions in 7.1% of the patients.
Conclusion: Parental use of CAMs to treat their children with epilepsy, asthma and sickle cell anaemia is
common in Nigeria. Efforts should be made by doctors taking care of these patients to identify those CAM
therapies that are beneficial, harmless and cheap for possible integration with conventional therapy.
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Background
The use of complementary and alternative medicine
(CAM) is on the increase globally with a high prevalence
in developed countries [1]. In developing countries, about
80% of the population are dependent on traditional heal-
ing methods, including herbal remedies, for health main-
tenance and therapeutic management of diseases [1]. In
most developing countries, use of herbal remedies is rela-
tively common and has been reported with a prevalence
of 20–80% in the Caribbean [2,3], Trinidad [4,5], South
Africa [6] and Nigeria [7,8]. The use of herbal remedies for
young and old patients with chronic health conditions
such as diabetes [9], asthma [10,11], epilepsy [7,12],
sickle cell anaemia [13], hypertension [8], HIV infection
and cancer [14,15], has also been widely reported.
CAM use in acutely ill children has been reported in
Nigeria [16,17]; traditional/herbal medicines being the
most frequently used CAMs. According to the World
Health Organisation (WHO), herbal medicines are the
first line of treatment for 60% of children with high fever
due to malaria in Nigeria, Ghana, Mali and Zambia [18].
Cough and abdominal pains are other symptoms of chil-
dren that are frequently treated with CAM in Nigeria
[16,17]. Herbal CAM therapies are frequently obtained
from traditional herbal medicine practitioners [19,20].
About 85% of Nigerians are known to use and consult tra-
ditional medicine for healthcare, social and psychological
benefits because of poverty and disillusionment with con-
ventional medical care [21]. Among the multitude of
herbal medicines in circulation in Nigeria, only about
twenty have been registered by the National Agency for
Food and Drug Agency and Control (NAFDAC), and most
of those are imported [22]. Only advertisements with
NAFDAC endorsement are allowed in print and electronic
media [22], yet aggressive strategies such as radio, televi-
sion and motorcade announcements have been adopted
by many unregistered CAM practitioners to market their
products, which are freely available for purchase on the
open market [23]. The danger of this is that misleading
information is given about the herbal products and self-
medication is encouraged, potentially endangering the
lives of many people.
The importance of traditional medicine in Nigerian
healthcare has been recognised by the national govern-
ment. In December, 2006 they set up a high profile com-
mittee to develop, promote and commercialise traditional
medicine products [24]. Efforts have also been made by
the government to preserve indigenous Nigerian medical
knowledge by boosting research into traditional medicine
[24].
Extracts of plants and animals from diverse parts of
Nigeria have been found to be useful for treating malaria
[25,26], epilepsy [27], dementia [28], sickle cell anaemia
[29-31] and bronchial asthma [32]. The potential toxicity
of herbal medicines and their products due to their high
levels of heavy metals [33,34], microbial contamination
[35,36] and lack of safety warnings on their labels [23] are
of concern regarding their use for treating children.
Complementary and alternative medicines are practices of
patient treatment that are not integral parts of the conven-
tional or orthodox medicine taught in medical schools
[15]. Therefore, both physicians and patients may lack
knowledge of the potential risks of adverse effects of
herbal remedies [37]. Such adverse reactions are common
[6,38] and may be linked to a lack of clinical trials on
humans [39]. Use of CAM, specifically for chronic health
conditions, has been reported to affect treatment outcome
adversely [40]. Multiple therapy practices involving com-
bined use of CAM (particularly herbal medicines) and
prescribed medicines is common in some adult [41] and
paediatric [10,13] populations.
Despite the abundance of studies on the use of CAM for
all age groups around the world, none has explored it for
children with chronic health conditions in Nigeria or
other African countries. This study is therefore focused on
the prevalence, pattern of use, parental sources of infor-
mation, perceived benefits and cost of CAM for children
with epilepsy, sickle cell anaemia and asthma. The adverse
effects of CAM were also evaluated.
Methods
This prospective study involved 318 paediatric patients
with epilepsy (122), asthma (78) and sickle cell anaemia
(118). These patients were recruited from the paediatric
neurology, respiratory and haematology clinics of the
LASUTH over a three month period (April to June 2007).
Each clinic is held once in a week (respiratory clinic on
Mondays, haematology and neurology clinics on Thurs-
days). On average, 50–60 patients are seen per visit at each
of the haematology and neurology clinics, while fewer
patients are seen per visit at the respiratory clinic.
The study was approved by the ethics committee of the
hospital. The study instrument was a structured interview-
administered questionnaire.
The Questionnaire
The questionnaire (Additional file 1) was developed from
previous studies on CAM use in paediatric and adult
patients with chronic illnesses, especially those with epi-
lepsy, sickle cell anaemia and asthma [2-8,10,11,13]. It
was used to obtain the following information: demogra-
phy of both the parents and their children with epilepsy,
sickle cell anaemia or asthma; past and present treatments
received by the patient; and the type of CAM, if any, usedBMC Complementary and Alternative Medicine 2008, 8:66 http://www.biomedcentral.com/1472-6882/8/66
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by the patient. Information was also obtained on the
sources, cost, benefits and adverse effects of the CAM
used. The questions asked were both open- and close-
ended. CAM use was considered as the use of either a com-
plementary or an alternative therapy according to the clas-
sification by the National Institute of Health [42].
The list of biological CAM (aloe vera, Forever Living®
products, GNLD® products, Jobelyn® products, Tianshi®
products, Yem-kem® products, ginger, lemongrass, and
ginseng products) used in this study was obtained from
previous studies evaluating CAM use in Nigeria [7,8], and
from community pharmacies and CAM practitioners in
Lagos. Samples of the biological CAM products and pho-
tographs of the different alternative medical practices in
Lagos, Nigeria (body scarification, charm wearing, ritual
sacrifice, concoction, Chinese medicine, homeopathy,
Ayurveda, and bone setting) were shown to the parents
during the open-ended interview to remind them of their
child's CAM use and prompt their responses. The mind-
body system therapies listed in the questionnaire (spirit-
ual healing/prayer, visualization, meditation, hypnosis
and divination/incantation) were also explained to the
parents during the open-ended interview.
Patients who had used CAM at least once in the last six
months during present illness were regarded as CAM
users; those who had not used CAM at all for the present
illness were considered non-users; and those who had
used CAM for the present illness but not during the previ-
ous six months were considered CAM-exposed.
The questionnaire was initially pre-tested at the oncology
clinic amongst patients with childhood tumours. Modifi-
cations were made, based on the observations of the par-
ents.
Patient recruitment
The patients were selected randomly on consecutive pres-
entation to the clinics so as to avoid interviewing a patient
twice or more. Only their parents were interviewed; other
caregivers were excluded because they may not have been
able to give a proper history of the child's illness. Critically
ill patients were also excluded so as not to delay care.
Other inclusion criteria were proper diagnosis of the ill-
ness in the patient and documentation of the result in the
case file (epilepsy diagnosed by EEG; sickle cell anaemia
confirmed by genotype test; and asthma with a good his-
tory, significant findings on physical examination, and a
lung function test that was in keeping with asthma), and
regular clinic attendance for at least six months. The study
was explained to parents who agreed to participate. They
were assured that the information tendered during the
interview would be treated with utmost confidentiality
and that their decision to participate in the study or oth-
erwise would not influence the treatment their child
would receive.
Parents were interviewed in the waiting room where the
vital signs of their children were taken. Each mother was
interviewed by one of the researchers (KAO and IOS) or
the research assistant, after the contents of the question-
naire had been explained to them in the native language
(illiterate parents) or English (literate parents). Parents
were classified according to their monthly income as low-
(less than  20,000 i.e < US$170 at 118 = US$ 1), medium-
(between  20,000 –  200,000 i.e <US$170–1,700) or high-
(above  200,000 i.e > US$ 1,700) income earners.
Data were analysed using SPSS 13. Chi-square analysis
was used for association between categorical variables and
Student's t-test for continuous variables at a significance
value of P < 0.05.
Results
Demographics of parents and their children
A total of 318 parents whose children had epilepsy (122,
38%); asthma (78, 25%) or sickle cell anaemia (118,
37%) were interviewed. The parents were predominantly
female (69%), educated up to secondary school level and
beyond (67%), and of low income (59%). Forty parents
(13%) were not educated at all. The overall mean age of
the parents was 32.1 ± 5.3 years.
The overall mean age of the patients was 4.5 ± 3.7 years.
There was no significant difference in the mean age
among the three groups (P = 0.08). One hundred and
sixty nine (53%) of these children were male. The overall
mean duration of illness was 3.8 ± 2.2 years (epilepsy: 4.2
± 2.1 years, asthma: 3.8 ± 1.8 years, sickle cell anaemia:
3.3 ± 1.6 years) and the overall mean duration of clinic
attendance was 23.4 ± 6.2 months.
Current medications of the patients
Table 1 shows the list of drugs prescribed to the patients.
They were all taking regular prescribed medications. Anti-
biotics (114, 41%), antimalarials (97, 31%) and analge-
sics (86, 25%) were the three medicines most frequently
used by the patients in addition to their regular medicines.
Profile of CAM utilisation
CAM was reportedly used by 99 (31%) patients (epilepsy
– 38%, asthma – 25%, sickle cell anaemia -36%). Among
these patients, 83 (84%) were currently using CAM
(users). The use of CAM was stopped six months prior to
the study by 16 (16%) patients (exposed).
The specific CAMs used are listed in Table 2. A total of 303
CAMs (either alone or in combination with other CAM)
were used by the patients. Biological products were theBMC Complementary and Alternative Medicine 2008, 8:66 http://www.biomedcentral.com/1472-6882/8/66
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most frequently used CAMs (58%), followed by alterna-
tive medical systems (27%). Fifty-one patients (52%)
were using more than one biological product at a time.
Based on the classification of CAMs, none of the patients
used energy therapy. The only manipulation and touch
CAM therapy was massage, which was used for asthma (2)
and sickle cell anaemia (4).
Relatives, friends and neighbours influenced 78 (79%) of
the parents to use CAM for their children. Other sources
of information about CAM to the parents included the
media: television, radio and newspaper advertisements
(13, 13%); CAM practitioners (5, 5%); churches (2%);
open market advertisements (2%); and hospital staff
(1%).
Most of the patients (72, 73%) used CAM daily; a few
used them weekly (15, 16%) or occasionally (9%). None
of the parents disclosed to doctors that they used CAM for
their children. The two main reasons for this were doctors
not asking the parents (84, 84.8%) and fear of the child
not being treated (15, 15.2%). However, the 84 parents
who were not asked about CAM use for their children
were willing to discuss such use if asked by the doctors.
The average cost per month amongst the majority who
used CAM every day was  8, 500 (US$ 70.1).
The parents used CAM to treat or cure their children
directly (80, 80%), improve their physical condition (26,
26%) or relieve symptoms of illness (17, 17%). A signifi-
cantly higher number of the sickle cell anaemic patients
used CAM to improve their body immunity (sickle cell
anaemia -10, asthma -1; P < 0.001). About half the par-
ents (46%) felt they observed some specific benefits in
their children after using CAM. These included improve-
ment in general well being (20%), relief of symptoms of
the illness (18%) and complete cure of the illness (7%).
Thirty-two (32%) of the parents observed some benefits
of CAM in their child that were inexplicable, while 16
(16%) observed no benefit.
Table 1: List of prescribed drugs taken by the patients.
Type of medication and illness Number of patient Percentage of patient
(%)
Epilepsy (n = 122)
Carbamazepine 84 69
Phenobarbitone 68 56
Valporic acid 42 34
Others
▪ Antimalarials 32 26
▪ Antibiotics 28 23
▪ Analgesics 18 15
Asthma (n = 78)
Salbutamol 48 62
Prednesolone 32 41
Aminophylline 25 32
Inhaler
▪ Beclamethasone 18 23
▪ Salbutamol 14 18
▪ Salmeterol 56
Others
▪ Antimalarials 17 22
▪ Antibiotics 23 30
▪ Analgesics 16 21
Sickle cell anaemia (n = 118)
Folic acid 118 100
Proguanil 106 90
Vitamin B-complex 77 65
Ascorbic acid 65 55
Amino acid supplement 45 38
Multivitamin 41 35
Others
▪ Antimalarials (except proguanil) 48 41
▪ Antibiotics 59 50
▪ Analgesics 52 44BMC Complementary and Alternative Medicine 2008, 8:66 http://www.biomedcentral.com/1472-6882/8/66
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CAM was discontinued six months previously by 16
patients because of adverse reactions (7), dissatisfaction
(7) or lack of benefits (2). Specific adverse reactions to
CAMs observed were over-sedation or hyperactivity in epi-
leptic patients (2), frequent exacerbation of difficulty in
breathing in the asthmatic patients (3), and fever, diar-
rhoea and vomiting in the sickle cell anaemic patients (2).
Discussion
Most studies evaluating CAM use for children have used
self-administered questionnaires, which have significant
limitations such as the use of terms and concepts that are
confusing to parents/caregivers, and poorer response rates
from incomplete filling of the questionnaire [13,43-49].
These limitations were addressed in the present study by
the researchers or the research assistants conducting the
interviews, providing samples of the biological CAM
products and photographs of the different alternative
medical practices available in Lagos, and explaining each
of the terminologies used in the questionnaire to the par-
ents. This method of interview also eliminated incom-
plete filling-in of the questionnaires by the parents.
Table 2: Types of CAM used by patients
Types Percentage of Frequency of use of CAM
Epilepsy
(n = 38)
Asthma
(n = 25)
Sickle cell anaemia
(n = 36)
Total CAM used (%)
Biological products
Ginger 18 12 15 45
Herbs 13 8 15 36
Jobelyn® product 3 1 16 20
Yem-Kem® product 8 3 5 16
Special diet/Nutritional
therapy 6 5 3 14
Lemongrass 6 0 8 14
Aloe vera® 64 4 1 4
Forever living® products 10 0 2 12
GNLD® product 0 2 0 2
Tianshi® product 2 0 0 2
Total 175 (58)
Alternative medical systems
Ritual sacrifice 5 2 6 13
Black soap bath 6 1 6 13
Blessed/anointed water 5 0 6 11
Blessed/anointed oil 3 1 5 9
Bone setting 0 0 9 9
Concoction soup 4 2 3 9
Scarification of body 3 0 5 8
Wearing of charms 1 0 2 3
Homeopathy 1 1 1 3
Ayurveda 0 1 1 2
Chinese medicine 0 0 1 1
Total 81 (27)
Mind- body interventions
Spiritual healing/prayer 15 8 12 35
Meditation 3 0 0 3
Visualisation 2 0 0 2
Hypnosis 1 0 0 1
Total 41 (13)
Others
Massage 0 2 4 6
Total 6 (2)
Forever Living® and GNLD® (Golden Neo Lite Diamite) products are nutritional health supplement and mega-dose multivitamins; Tianshi® products 
are Chinese nutritional health supplements and natural products; Jobelyn® product is an immune booster nutritional supplement containing 
Sorghum leaf extract; Yem-kem® product is for curing blood and contains Cinchona 15%, Khaya ivorensis 10%, Theobroma cocoa 35% and 
Colocaste antoguorum 40%.BMC Complementary and Alternative Medicine 2008, 8:66 http://www.biomedcentral.com/1472-6882/8/66
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Previous studies that have reported adverse reactions to
CAM therapies did not look into the chronic toxicities of
the biological products [44-50]; we therefore used a re-call
period of six months, which we considered sufficient for
any chronic toxicity to manifest itself in the patients.
A prevalence of 31% was obtained in this study. This rate
is lower than the 44%–54% previously reported for
chronic childhood illnesses [10,13,46] but higher than
the 12%–23% reported for children with acute or stable
health conditions [44-46,48,49]. One may therefore be
tempted to believe that, globally, chronic health condi-
tions promote CAM use for children more than acute ill-
nesses. Unfortunately, this may not be true because of
variations in the definition of CAM and of differences in
population size between different studies.
Biological products were the CAMs most frequently used
for children in this study similar to the usages for acute
and chronic illnesses reported in the UK [50] and Aus-
tralia [10] but contrasting with the bioenergetic therapies
(prayer, spiritual and energy healing) and chiropractic
manipulations used for childhood tumours and neuro-
logical disorders in Canada [43,46] and for sickle cell
anaemia in the United States [13]. This variation showed
that environment probably influences the type of CAM
used for children.
Many studies have reported that mega-dose vitamins are
the most frequently used biological CAMs for children
[10,50]. Other studies, in contrast, have reported herbal
medicines as the most frequently used CAMs [44,51]. In
the present study, herbal medicines and their products
were the most frequently used biological products. These
patients were also on regular medications prescribed at
the clinic; therefore they were at risk of drug-herb interac-
tions. The risk of adverse herb-drug interactions is likely to
be higher in the 52% of patients who used more than one
biological product. Drug-herb interactions have been
reported in patients using both herbal CAMs and pre-
scribed medications [52,53]. This may explain the signifi-
cant life-threatening adverse reactions reported by some
parents in this study. The adverse reactions to CAMs
reported in other studies were few and mild [43,46,50],
probably because the biological products involved were
mega-dose vitamins, which are seldom associated with
severe adverse reactions [54].
The influence of relatives, friends and neighbours on a
patient's decision to use CAM has been reported in both
adults and children [7,46,47,50,51]. The high percentage
(79%) of parents influenced in this study by relatives,
friends and neighbours to use CAMs for their children is
comparable to the 60%–86% previously reported [50,51].
None of the parents in this study disclosed the use of CAM
for their children to the doctors, in contrast to the 63%
and 66% who reported CAM use in other studies [51,54].
High percentages (73%–81%) of parents who use CAM
for their children have been reported to be eager to discuss
such usage with their doctors [45,48,55]. A similar pro-
portion of mothers (85%) in this study was willing to dis-
cuss CAM use for their children with doctors but did not
do so because they were not asked. Doctors are therefore
advised to encourage parents to discuss CAM use for their
children freely during hospital visits and to be willing to
initiate discussions on this issue.
Only a few studies have looked at the cost of CAM
[10,46,50]. Soo et al [46] found no significant difference
in total median cost between CAM and conventional ther-
apies (31.7 US$ vs 50.0 US$ per month). Between £ 5 and
£20 per month was expended on non-medicinal CAM for
children and adolescents in Wales [53], and $A 25–400
per month for children with asthma in Australia [10].
Approximately US$ 70.1 per month was expended on
CAMs by each parent in the present study. This is almost
twice the median amount spent on CAMs in other studies
[10,46,50]. Since most of the parents in this study were
low-income earners, this appears to be significant amount
and may cause an economic drain on their purses. It
would have been more appropriate to compare CAM costs
with conventional therapy costs for these patients, but this
was not done because healthcare treatment is free for chil-
dren in Lagos.
CAM therapy has been reported to be beneficial for chil-
dren by some parents [10,13,43,44]. Such benefits
included prevention of illness, maintenance of good
health, relief of musculoskeletal pain, control of asthma
symptoms, treatment of mild respiratory problems, relief
of pain in sickle cell anaemia and enhancement of the
immune system in cancer. It is therefore not surprising to
see that 80% of parents used CAM to treat or cure their
children. It should be noted that the 7% of parents who
perceived their children as cured were among the 16 par-
ents who had discontinued CAM six months previously.
CAM was discontinued because the symptoms of the ill-
ness recurred in their children with exacerbation after
their regular medications had been discontinued. The fact
that approximately half the parents (46%) of the CAM
users reported some benefits of CAM to their children,
albeit non-specific, calls for clinical trials of CAMs to
establish parents' claim and assess the safety of the ther-
apy for children.
This study has focused on evaluating CAM use in children
with chronic illnesses. A comparative study with a control
cohort of Nigerian children with no illness would haveBMC Complementary and Alternative Medicine 2008, 8:66 http://www.biomedcentral.com/1472-6882/8/66
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provided more information about CAM use. This is how-
ever another limitation of the study.
Conclusion
CAM use is a common phenomenon amongst children
with epilepsy, sickle cell anaemia and asthma in Lagos,
Nigeria. Parents considered CAM to be beneficial for their
children and were willing to discuss its use with their doc-
tors. Paediatric doctors should initiate discussion on CAM
use during clinic visits to enable parents to make
informed decisions about it. Clinical trials of the biologi-
cal CAM products should be done to ensure that these
products are safe for children.
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